MeSH tree: C15.378.100
Patients with the genetic disorder hemophilia A receive factor VIII protein replacement treatments to replenish this clotting protein in their blood, thus preventing dangerous bleeding. Unfortunately, about 30% of these patients ...
Aug 14, 2023
0
54
Immunothrombosis, or the formation of microscopic blood clots during inflammation, is a major cause of morbidity among patients with sepsis or severe COVID-19. A key enzyme in this process is thrombin. To date, no method ...
Aug 10, 2023
0
48
The U.S. Food and Drug Administration on Thursday approved a costly single-dose gene therapy for patients with severe hemophilia A, a life-threatening hereditary bleeding disorder.
Jul 3, 2023
0
70
Scientists from Trinity College Dublin have just discovered that the drug dimethylfumarate can block blood clotting during infection, offering hope that it could be used to treat a number of conditions, such a life-threatening ...
Jun 21, 2023
0
71
The chances of surviving massive blood loss from a traumatic injury such as a gunshot wound are around 50%. To survive, a patient needs two things to happen quickly: a large infusion of blood and coagulation at the wound ...
Jun 14, 2023
1
113
Catherine Reitzel's multiple sclerosis medication costs nearly $100,000 a year. Kris Garcia relies on a drug for a blood-clotting disorder that runs $10,000 for a three-day supply. And Mariana Marquez-Farmer would likely ...
May 31, 2023
0
73
According to a study published in the American Journal of Roentgenology (AJR), frequencies of imaging-apparent and palpable hematoma were not significantly different between patients temporarily discontinuing versus maintaining ...
May 10, 2023
0
43
"Don't poke the bear," they said. But that's exactly what a team of scientists have been doing to discover the secrets of blood clotting.
Apr 13, 2023
0
76
The rate of cardiac arrest during delivery hospitalizations is 13.4 per 100,000, with cardiac arrest occurring more often among older patients, non-Hispanic Blacks, and those with an underlying medical condition, according ...
Mar 14, 2023
0
51
For patients with hemophilia B, one infusion of adeno-associated virus 5 (AAV5) vector expressing the Padua factor IX variant (etranacogene dezaparvovec) is noninferior and superior to prophylaxis with factor IX, according ...
Mar 3, 2023
0
53
